Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Featured trial
A Safety and Efficacy Study of Ruxolitinib Cream Combined With Narrow-Band Ultraviolet B Phototherapy in Participants With Vitiligo

The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom

segmental vitiligo
phototherapy
  • 17 views
  • 17 Sep, 2022
  • 8 locations
Featured trial
  • 0 views
  • 19 Sep, 2022
Featured trial
Do you or your child have Vitiligo?

Doctors at Advanced Pharma - Miami are conducting a clinical trial study of an investigational cream for Vitiligo. If you or your child are 12 years of age or older and have Vitiligo on both the

  • 264 views
  • 09 Dec, 2020
  • 1 location
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation (ERASE)

Vitiligo affects 1 to 2% of worldwide population and has a demonstrated impact on the quality of life. Optimal treatment of vitiligo requires to target the auto-immune inflammatory

systemic steroids
skin biopsy
hypopigmentation
tubal ligation
segmental vitiligo
  • 0 views
  • 28 Jun, 2022
  • 2 locations
A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)

The purpose of the study is to evaluate the Mechanism Of Action (MOA) of ruxolitinib cream in vitiligo by assessing the change in biomarkers.

skin biopsy
  • 38 views
  • 11 Apr, 2022
  • 13 locations
Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo

Vitiligo is the commonest acquired depigmenting disorder characterized by loss of melanocytes from the basal layer of skin causing white patches which leads to great psychological distress in

psychiatric problems
Accepts healthy volunteers
  • 0 views
  • 23 Mar, 2022
  • 1 location
A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Mechanism of Action of Ruxolitinib Cream for Vitiligo

The purpose of the study is to evaluate the Mechanism Of Action (MOA) of ruxolitinib cream in vitiligo by assessing the change in biomarkers.

  • 0 views
  • 14 Sep, 2022
  • 5 locations
Evaluation of AMG 714 for Vitiligo: A Phase 2a Randomized Double Blind Placebo Controlled Trial (ITN086AI) (REVEAL)

This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.

phototherapy
  • 152 views
  • 23 Sep, 2022
  • 6 locations
Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma (VITILIMEL)

complete lack of response against cancer cells. Indeed, both melanoma and vitiligo are pathologies where the immune system plays an important role in the progression of the disease. Advanced stage

  • 0 views
  • 22 Jul, 2022
  • 1 location
A Safety and Efficacy Study of Ruxolitinib Cream Combined With Narrow-Band Ultraviolet B Phototherapy in Participants With Vitiligo

The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom

segmental vitiligo
phototherapy
  • 9 views
  • 17 Sep, 2022
  • 8 locations